Impulse control disorders in parkinson's disease: A psychosocial perspective

Journal of Clinical Psychology in Medical Settings

Volumn 19, Issue 3, 2012, Pages 338-346

  Delaney, Mary ^a   Leroi, Iracema ^b   Simpson, Jane ^a   Overton, Paul Geoffrey ^c,d  

^a PENNINE CARE NHS FOUNDATION TRUST   (United Kingdom)

^b ROYAL BLACKBURN HOSPITAL   (United Kingdom)

^c LANCASTER UNIVERSITY   (United Kingdom)

^d UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Compulsion; Dopamine agonist; Dopamine replacement therapy; Psychological; Social

Indexed keywords

ARTICLE; CONCEPTUAL FRAMEWORK; COPING BEHAVIOR; DISEASE COURSE; DISTRESS SYNDROME; DOPAMINERGIC NERVE CELL; FIBROMYALGIA; HUMAN; HYPERSEXUALITY; IMPULSE CONTROL DISORDER; MEDICAL RESEARCH; MENTAL PATIENT; PARKINSON DISEASE; PATHOLOGY; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; REINFORCEMENT; SOCIAL PSYCHOLOGY;

ANTIPARKINSON AGENTS; COMORBIDITY; DOPAMINE AGONISTS; FEMALE; HUMANS; IMPULSE CONTROL DISORDERS; MALE; MODELS, PSYCHOLOGICAL; PARKINSON DISEASE; STRESS, PSYCHOLOGICAL;

EID: 84867336676     PISSN: 10689583     EISSN: 15733572     Source Type: Journal    
DOI: 10.1007/s10880-012-9302-7     Document Type: Article

References (71)

1. American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed. Text Revision). Washington, DC: American Psychiatric Association.
2. Antonini, A., Siri, C., Santangelo, G., Cilia, R., Poletti, M., Canesi, M., et al. (2011). Impulsivity and compulsivity in drug-naïve patients with Parkinson's disease. Movement Disorders, 26, 464-468.
3. Ardouin, C., Voon, V., Worbe, Y., Abouazar, N., Czernecki, V., Hosseini, H., et al. (2006). Pathological gambling in Parkinson's disease improves on chronic subthalamic nucleus stimulation. Movement Disorders, 21, 1941-1946.
4. Barbeau, A. (1969). L-Dopa therapy in Parkinson's disease: A critical review of 9 years' experience. Canadian Medical Association Journal, 101, 59-68.
5. Berridge, K. C., & Robinson, T. E. (1998). What is the role of dopamine in reward: Hedonic impact, reward learning, or incentive salience? Brain Research Reviews, 28, 309-369.
6. Black, D. W. (2007). A review of compulsive buying disorder. World Psychiatry, 6, 14-18.
7. Bland, R. C., Newman, S. C., Orn, H., & Stebelsky, G. (1993). Epidemiology of pathological gambling in Edmonton. Canadian Journal of Psychiatry, 38, 108-112.
8. Bonvin, C., Horvath, J., Christe, B., Landis, T., & Burkhard, P. R. (2007). Compulsive singing: Another aspect of punding in PD. Annals of Neurology, 62, 525-528.
9. Bramley, N., & Eatough, V. (2005). The experience of living with Parkinson's disease: An interpretative phenomenological analysis case study. Psychology and Health, 20, 223-235.
10. Brown, R. G., & Jahanshahi, M. (1995). Depression in Parkinson's disease: A psychosocial viewpoint. Advances in Neurology, 65, 61-84.
11. Ceschin, L., Giannunzio, V., Favaro, A., & Santonastaso, P. (2010). Pica in an eating disordered woman with multiple sclerosis: Impulse dys-control, compulsive symptom or self-medication attempt? Eating and Weight Disorders, 15, e116-e118.
12. Clarke, C. E., & Guttman, M. (2002). Dopamine agonist monotherapy in Parkinson's disease. Lancet, 360, 1767-1769.
13. Devos, D., Dujardin, K., Poirot, I., Moreau, C., Cottencin, O., Thomas, P., et al. (2008). Comparison of desipramine and citalopram treatments for depression in Parkinson's disease: A double-blind, randomized, placebo-controlled study. Movement Disorders, 23, 850-857.
14. Dodd, M. L., Klos, K. J., Bower, J. H., Geda, Y. E., Josephs, K. A., & Ahlskog, E. (2005). Pathological gambling caused by drugs used to treat Parkinson's disease. Archives of Neurology, 62, 1-5.
15. Evans, A. H., & Butzkueven, H. (2007). Dopamine induced pathological gambling in restless legs syndrome due to multiple sclerosis. Movement Disorders, 22, 590-591.
16. Evans, A. H., Katzenschlager, R., Paviour, D., O'Sullivan, J. D., Appel, S., Lawrence, A. D., et al. (2004). Punding in Parkinson's disease: Its relation to dopamine dysregulation syndrome. Movement Disorders, 19, 397-405.
17. Farabaugh, A., Locascio, J. J., Yap, L., Growdon, J., Fava, M., Crawford, C., et al. (2010). Cognitive-behavioral therapy for patients with Parkinson's disease and comorbid major depressive disorder. Psychosomatics, 51, 124-129.
18. Fitzpatrick, L., Simpson, J., & Smith, A. (2010) A qualitative analysis of mindfulness-based cognitive therapy (MBCT) in Parkinson's disease. Psychology and Psychotherapy, 83, 179-192.
19. Gallagher, D. A., O'Sullivan, S. S., Evans, A. H., Lees, A. J., & Schrag, A. (2007). Pathological gambling in Parkinson's disease: Risk factors and differences from dopamine dysregulation: An analysis of published case series. Movement Disorders, 12, 1757-1763.
20. Giladi, N., Weitzman, N., Schreiber, S., Shabtai, H., & Peretz, C. (2007). New onset heightened interest or drive for gambling, shopping, eating or sexual activity in patients with Parkinson's disease: The role of dopamine agonist treatment and age at motor symptom onset. Journal of Psychopharmacology, 21, 501-506.
21. Grant, J. E., & Kim, S. W. (2001). Demographic and clinical features of 131 adult pathological gamblers. Journal of Clinical Psychiatry, 62, 957-962.
22. Grant, J. E., & Potenza, M. N. (2004). Impulse control disorders: Clinical characteristics and pharmacological management. Annals of Clinical Psychiatry, 16, 27-34.
23. Greeno, C. G., & Wing, R. R. (1994). Stress-induced eating. Psychological Bulletin, 115, 444-464.
24. Holden, C. (2001). Behavioural addictions: Do they exist? Science, 294, 980-982.
25. Hollander, E., DeCaria, C. M., Finkell, J. N., Begaz, T., Wong, C. M., & Cartwright, C. A. (2000). A randomised double-blind fluvoxamine/placebo crossover trial in pathologic gambling. Biological Psychiatry, 47, 813-817.
26. Holman, A. J. (2009). Impulse control disorder behaviours associated with pramipexole used to treat fibromyalgia. Journal of Gambling Studies, 25, 425-431.
27. Hudson, J. I., Hiripi, E., Pope, H. G, Jr, & Kessler, R. C. (2007). The prevalence and correlates of eating disorders in the National Comorbidity Survey Replication. Biological Psychiatry, 61, 348-358.
28. Isaias, I. U., Siri, C., Cilia, R., De Gaspari, D., Pezzoli, G., & Antonini, A. (2008). The relationship between impulsivity and impulse control disorders in Parkinson's disease. Movement Disorders, 23, 411-415.
29. Kim, S. W., Grant, J. E., Adson, D. E., Shin, Y. C., & Zaninelli, R. (2002). A double-blind placebo-controlled study of the efficacy and safety of paroxetine in the treatment of pathological gambling. Journal of Clinical Psychiatry, 63, 501-507.
30. Klos, K. J., Bower, J. H., Josephs, K. A., Matsumoto, J. Y., & Ahlskog, J. E. (2005). Pathological hypersexuality predominantly linked to adjuvant dopamine agonist therapy in Parkinson's disease and multiple system atrophy. Parkinsonism and Related Disorders, 11, 381-386.
31. Kulisevsky, J., Pagonabarraga, J., Pascual-Sedano, B., Garcia-Sánchez, C., & Gironell, A. (2008). Trapecio Group Study. Prevalence and correlates of neuropsychiatric symptoms in Parkinson's disease without dementia. Movement Disorders, 23, 1889-1896.
32. Kumru, H., Santamaria, J., Valldeoriola, F., Marti, M., & Tolosa, E. (2006). Increase in body weight after pramipexole treatment in Parkinson's disease. Movement Disorders, 21, 1972-1974.
33. Kurlan, R. (2004). Disabling repetitive behaviours in Parkinson's disease. Movement Disorders, 19, 433-437.
34. Lee, J. Y., Kim, J. M., Kim, J. W., Cho, J., Lee, W. Y., Kim, H. J., et al. (2010). Association between the dose of dopaminergic medication and the behavioral disturbances in Parkinson disease. Parkinsonism and Related Disorders, 16, 202-207.
35. Lejoyeux, M., Arbaretaz, M., McLoughlin, M., & Ades, J. (2002). Impulse control and depression. Journal of Nervous and Mental Disease, 190, 310-314.
36. Lim, S., Evans, A. H., & Miyasaki, J. M. (2008). Impulse control and related disorders in Parkinson's disease. Annals of the New York Academy of Science, 1142, 85-197.
37. MacCarthy, B., & Brown, R. G. (1989). Psychosocial factors in Parkinson's disease. British Journal of Clinical Psychology, 28, 41-52.
38. Mamikonyan, E., Siderowf, A. D., Duda, J. E., Potenza, M. N., Horn, S., Stern, M. B., et al. (2008). Long-term follow up of impulse control disorders in Parkinson's disease. Movement Disorders, 23, 75-80.
39. Martinkova, J., Trejbalova, L., Sasikova, M., Benetin, J., & Valkovic, P. (2011). Impulse control disorders associated with dopaminergic medication in patients with pituitary adenomas. Clinical Neuropharmacology, 34, 179-181.
40. McKeon, A., Josephs, K. A., Klos, K. J., Hecksel, K., Bower, J. H., Bostwick, M. J., et al. (2007). Unusual compulsive behaviors primarily related to dopamine agonist therapy in Parkinson's disease and multiple system atrophy. Parkinsonism and Related Disorders, 13, 516-519.
41. Mendez, M. F., Bronstein, Y. L., & Christine, D. L. (2000). Excessive sweepstakes participation by persons with dementia. Journal of the American Geriatrics Society, 48, 855-856.
42. Mercury, M. G., Tschan, W., Kehoe, R., & Kuechler, A. (2007). The presence of depression and anxiety in Parkinson's disease. Disease-a-month, 53, 296-301.
43. Merims, D., & Giladi, N. (2008). Dopamine dysregulation syndrome, addiction and behavioral changes in Parkinson's disease. Parkinsonism and Related Disorders, 14, 273-280.
44. Minzer, K., Lee, O., Hong, J. J., & Singer, H. S. (2004). Increased prefrontal D2 protein in Tourette syndrome: A postmortem analysis of frontal cortex and striatum. Journal of Neurological Science, 219, 55-61.
45. Molina, J. A., Sainz-Artiga, M. J., Fraile, A., Jimenez-Jimenez, F. J., Villaneuva, C., Orti-Pareja, M., et al. (2001). Pathologic gambling in Parkinson's disease: A behavioural manifestation of pharmacologic treatment? Movement Disorders, 15, 869-872.
46. Obeso, J. A., Rodriguez-Oroz, M. C., Rodriguez, M., Lanciego, J. L., Artieda, J., Gonzalo, N., et al. (2000). Pathophysiology of the basal ganglia in Parkinson's disease. Trends in Neurosciences, 23, S8-S19.
47. O'Sullivan, S. S., Djamshidian, A., Ahmed, Z., Evans, A. H., Lawrence, A. D., Holton, J. L., et al. (2010). Impulsive-compulsive spectrum behaviors in pathologically confirmed progressive supra-nuclear palsy. Movement Disorders, 25, 638-642.
48. Piers, G., & Singer, M. (1971). Shame and guilt: A psychoanalytic and cultural study. New York: Norton.
49. Pietrzak, R. H., Morasco, B. J., Blanco, C., Grant, B., & Petry, N. (2007). Gambling level and psychiatric and medical disorders in older adults: Results from the National Epidemiologic Survey on alcohol and related conditions. American Journal of Geriatric Psychiatry, 15, 301-313.
50. Pontone, G., Williams, J. R., Bassett, S. S., & Marsh, L. (2006). Clinical features associated with impulse control disorders in Parkinson's disease. Neurology, 67, 1258-1261.
51. Potenza, M. N., Voon, V., & Weintraub, D. (2007). Drug insight: Impulse control disorders and dopamine therapies in Parkinson's disease. Nature Clinical and Practical Neurology, 3, 664-672.
52. Quinn, N. P., Toone, B., Lang, A. E., Marsden, C. D., & Parkes, J. D. (1983). Dopa dose dependent sexual deviation. British Journal of Psychiatry, 142, 296-298.
53. Redgrave, P., Coizet, V., Comoli, E., McHaffie, J. G., Leriche, M., Vautrelle, N., et al. (2010). Interactions between the midbrain superior colliculus and the basal ganglia. Frontiers in Neuroanatomy, 22, 4.
54. Rook, D. W. (1987). The buying impulse. Journal of Consumer Research, 14, 189-199.
55. Schrag, A., Hovris, A., Morley, D., Quinn, N., & Jahanshahi, M. (2003). Young-versus older-onset Parkinson's disease: Impact of disease and psychosocial consequences. Movement Disorders, 18, 1250-1256.
56. Singer, E. (1973). Social costs of Parkinson's disease. Journal of Chronic Disease, 26, 243-254.
57. Siri, C., Cilia, R., De Gaspari, D., Villa, F., Goldwurm, S., Marco, C., et al. (2010). Psychiatric symptoms in Parkinson's disease assessed with the SCL-90R self-reported questionnaire. Neurological Science, 31, 35-40.
58. Sproesser, E., Viana, M. A., Quagliato, E. M., & de Souza, E. A. (2010). The effect of psychotherapy in patients with PD: A controlled study. Parkinsonism and Related Disorders, 16, 298-300.
59. Sproston, K., Erens, R., & Orford, J. (2000). Gambling behaviour in Britain: Results from the British gambling prevalence survey. London: National Centre for Social Research.
60. Stamey, W., & Jankovic, J. (2008). Impulse control disorders and pathological gambling in patients with Parkinson disease. Neurologist, 14, 89-99.
61. Starkstein, S. E., Berthier, M. L., Bolduc, P. L., Preziozi, T. J., & Robinson, R. G. (1989). Depression in patients with early onset versus later onset of Parkinson's disease. Neurology, 39, 1141-1145.
62. Stern, M. B. (1988). The clinical characteristics of Parkinson's disease and Parkinsonian syndromes: Diagnosis and assessment. In M. B. Stern & M. I. Hurtig (Eds.), The comprehensive management of Parkinson's disease (pp. 3-50). New York: PMA Publishing.
63. Tice, D. M., Bratslavsky, E., & Baumeister, R. F. (2001). Emotional distress regulation takes precedence over impulse control: If you feel bad, do it! Journal of Personality and Social Psychology, 80, 53-67.
64. Tippmann-Peikert, M., Park, J. G., Boeve, B. F., Shepard, J. W., & Silber, M. H. (2007). Pathologic gambling in patients with restless legs syndrome treated with dopaminergic agonists. Neurology, 68, 301-303.
65. Treves, T. A., Chandra, V., & Korczyn, A. D. (1993). Parkinson's and Alzheimer's diseases: Epidemiological comparison. 1. Descriptive aspects. Neuroepidemiology, 12, 336-344.
66. Uitti, R. J., Tanner, C. M., Rajput, A. H., Goetz, C. G., Klawans, H. L., & Thiessen, B. (1989). Hypersexuality with antiparkinsonian therapy. Clinical Neuropharmacology, 12, 66-70.
67. Voon, V., Potenza, N. M., & Thomsen, T. (2007a). Medication related impulse control and impulse control behaviours in Parkinson's disease. Current Opinion in Neurology, 20, 484-492.
68. Voon, V., Thomsen, T., Miyasaki, J. M., de Souza, M., Shafro, A., Fox, S. H., et al. (2007b). Factors associated with dopaminergic drug-related pathological gambling in Parkinson's disease. Archives of Neurology, 64, 212-216.
69. Voon, V., Sohr, M., Lang, A. E., Potenza, M. N., Siderowf, A. D., Whetteckey, J., Weintraub, D., Wunderlich G. R., & Stacy M. (2011) Impulse control disorders in Parkinson disease: A multicenter case-control study. Annal of Neurology, 69, 986-996.
70. Weintraub, D. (2008). Dopamine and impulse control disorders in Parkinson's disease. Annals of Neurology, 64, S93-S100.
71. Weintraub, D., Koester, J., Potenza, M. N., Siderowf, A. D., Stacy, M., Voon, V., et al. (2010). Impulse control disorders in Parkinson's disease: A cross-sectional study of 3090 patients. Archives of Neurology, 67, 589-595.